Rhumbline Advisers ARRIVENT BIOPHARMA INC Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025
Number of Shares
33,954
Previous 37,143 8.59%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
N/A
-3,189 Reduced 8.59%
33,954 $0
Q1 2025

Apr 08, 2025
BUY
N/A
453 Added 1.23%
37,143 $0
Q4 2024

May 29, 2025
SELL
N/A
-453 Reduced 1.22%
36,690 $0
Q4 2024

Jan 30, 2025
BUY
N/A
3,069 Added 9.13%
36,690 $0
Q3 2024

Nov 12, 2024
BUY
N/A
20,914 Added 164.59%
33,621 $0
Q2 2024

Aug 01, 2024
BUY
N/A
2,942 Added 30.13%
12,707 $0
Q1 2024

May 09, 2024
BUY
N/A
9,765 New
9,765 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email